145 related articles for article (PubMed ID: 11074560)
1. Mast cell disease associated with acute myeloid leukemia: detection of a new c-kit mutation Asp816His.
Pullarkat VA; Pullarkat ST; Calverley DC; Brynes RK
Am J Hematol; 2000 Dec; 65(4):307-9. PubMed ID: 11074560
[TBL] [Abstract][Full Text] [Related]
2. Systemic mastocytosis associated with acute myeloid leukaemia: report of two cases and detection of the c-kit mutation Asp-816 to Val.
Sperr WR; Walchshofer S; Horny HP; Födinger M; Simonitsch I; Fritsche-Polanz R; Schwarzinger I; Tschachler E; Sillaber C; Hagen W; Geissler K; Chott A; Lechner K; Valent P
Br J Haematol; 1998 Dec; 103(3):740-9. PubMed ID: 9858225
[TBL] [Abstract][Full Text] [Related]
3. Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder.
Nagata H; Worobec AS; Oh CK; Chowdhury BA; Tannenbaum S; Suzuki Y; Metcalfe DD
Proc Natl Acad Sci U S A; 1995 Nov; 92(23):10560-4. PubMed ID: 7479840
[TBL] [Abstract][Full Text] [Related]
4. Mastocytosis in mice expressing human Kit receptor with the activating Asp816Val mutation.
Zappulla JP; Dubreuil P; Desbois S; Létard S; Hamouda NB; Daëron M; Delsol G; Arock M; Liblau RS
J Exp Med; 2005 Dec; 202(12):1635-41. PubMed ID: 16352739
[TBL] [Abstract][Full Text] [Related]
5. Systemic mastocytosis with associated clonal hematological non-mast-cell lineage disease: analysis of clinicopathologic features and activating c-kit mutations.
Pullarkat VA; Bueso-Ramos C; Lai R; Kroft S; Wilson CS; Pullarkat ST; Bu X; Thein M; Lee M; Brynes RK
Am J Hematol; 2003 May; 73(1):12-7. PubMed ID: 12701114
[TBL] [Abstract][Full Text] [Related]
6. [Therapeutically relevant mutations in the receptor tyrosine kinase KIT in mastocytosis].
Sotlar K
Verh Dtsch Ges Pathol; 2007; 91():169-76. PubMed ID: 18314612
[TBL] [Abstract][Full Text] [Related]
7. Myelomastocytic overlap syndromes: biology, criteria, and relationship to mastocytosis.
Valent P; Sperr WR; Samorapoompichit P; Geissler K; Lechner K; Horny HP; Bennett JM
Leuk Res; 2001 Jul; 25(7):595-602. PubMed ID: 11377685
[TBL] [Abstract][Full Text] [Related]
8. c-Kit and c-kit mutations in mastocytosis and other hematological diseases.
Boissan M; Feger F; Guillosson JJ; Arock M
J Leukoc Biol; 2000 Feb; 67(2):135-48. PubMed ID: 10670573
[TBL] [Abstract][Full Text] [Related]
9. Amplification of a novel c-Kit activating mutation Asn(822)-Lys in the Kasumi-1 cell line: a t(8;21)-Kit mutant model for acute myeloid leukemia.
Beghini A; Magnani I; Ripamonti CB; Larizza L
Hematol J; 2002; 3(3):157-63. PubMed ID: 12111653
[TBL] [Abstract][Full Text] [Related]
10. Analysis of the surface expression of c-kit and occurrence of the c-kit Asp816Val activating mutation in T cells, B cells, and myelomonocytic cells in patients with mastocytosis.
Akin C; Kirshenbaum AS; Semere T; Worobec AS; Scott LM; Metcalfe DD
Exp Hematol; 2000 Feb; 28(2):140-7. PubMed ID: 10706069
[TBL] [Abstract][Full Text] [Related]
11. Effects of mutant c-Kit in early myeloid cells.
Ashman LK; Ferrao P; Cole SR; Cambareri AC
Leuk Lymphoma; 1999 Aug; 34(5-6):451-61. PubMed ID: 10492068
[TBL] [Abstract][Full Text] [Related]
12. C-kit mutations and mast cell disorders. A model of activating mutations of growth factor receptors.
Pignon JM
Hematol Cell Ther; 1997 Apr; 39(2):114-6. PubMed ID: 9168310
[TBL] [Abstract][Full Text] [Related]
13. Recent advances in the understanding of mastocytosis: the role of KIT mutations.
Orfao A; Garcia-Montero AC; Sanchez L; Escribano L;
Br J Haematol; 2007 Jul; 138(1):12-30. PubMed ID: 17555444
[TBL] [Abstract][Full Text] [Related]
14. Molecular changes associated with the development of resistance to imatinib in an imatinib-sensitive canine neoplastic mast cell line carrying a KIT c.1523A>T mutation.
Kobayashi M; Kuroki S; Tanaka Y; Moriya Y; Kozutumi Y; Uehara Y; Ono K; Tamura K; Washizu T; Bonkobara M
Eur J Haematol; 2015 Dec; 95(6):524-31. PubMed ID: 25684098
[TBL] [Abstract][Full Text] [Related]
15. Somatic c-KIT activating mutation in urticaria pigmentosa and aggressive mastocytosis: establishment of clonality in a human mast cell neoplasm.
Longley BJ; Tyrrell L; Lu SZ; Ma YS; Langley K; Ding TG; Duffy T; Jacobs P; Tang LH; Modlin I
Nat Genet; 1996 Mar; 12(3):312-4. PubMed ID: 8589724
[TBL] [Abstract][Full Text] [Related]
16. c-kit activating mutations and mast cell proliferation in human leukemia.
Beghini A; Larizza L; Cairoli R; Morra E
Blood; 1998 Jul; 92(2):701-2. PubMed ID: 9657776
[No Abstract] [Full Text] [Related]
17. The prognostic impact of c-KIT mutation in systemic mastocytosis associated with acute myeloid leukaemia patients.
Won D; Chi HS; Shim H; Jang S; Park CJ; Lee JH
Leuk Res; 2013 Aug; 37(8):883-8. PubMed ID: 23683787
[TBL] [Abstract][Full Text] [Related]
18. De novo mast cell leukemia without CD25 expression and KIT mutations: a rare case report in a 13-year-old child.
Zheng Y; Nong L; Liang L; Wang W; Li T
Diagn Pathol; 2018 Feb; 13(1):14. PubMed ID: 29458385
[TBL] [Abstract][Full Text] [Related]
19. A new c-kit mutation in a case of aggressive mast cell disease.
Pignon JM; Giraudier S; Duquesnoy P; Jouault H; Imbert M; Vainchenker W; Vernant JP; Tulliez M
Br J Haematol; 1997 Feb; 96(2):374-6. PubMed ID: 9029028
[TBL] [Abstract][Full Text] [Related]
20. Identification of activating c-kit mutations in adult-, but not in childhood-onset indolent mastocytosis: a possible explanation for divergent clinical behavior.
Büttner C; Henz BM; Welker P; Sepp NT; Grabbe J
J Invest Dermatol; 1998 Dec; 111(6):1227-31. PubMed ID: 9856847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]